Adolescent Performance Enhancing Substance Use: Regional Differences across the US

REFERENCES

• American Academy of Pediatrics (2005). Policy statement: Use of performance enhancing substances. Pediatrics, 115(4), 1103–06.
   PubMed Web of Science ®Google Scholar
• American College of Sports Medicine. (2003, March 13). News release ACSM urges young athletes to avoid ephedra. Retrieved June 16, 2011 from www.acsm.org/AM/Template.cfm?Section = Home_Page&template = /CM/ContentDisplay.cfm&ContentID =4234
   Google Scholar
• American Medical Association. (2008, Feb. 21). Report 9 of the Council of Scientific Affairs (A-03): Hormone abuse by adolescents. Retrieved June 16, 2011 from http://www.ama-assn.org/resources/doc/csaph/a03csa9-summary.pdf.
   Google Scholar
• Arvary, D., & Pope, H. G. (2000, May 18). Anabolic-androgenic steroids as a gateway to opioid dependence. New England Journal of Medicine, 342(20), 1532.
   PubMed Web of Science ®Google Scholar
• Bahrke, M. S., & Yesalis, C. E. (Eds.). (2002). Performance enhancing substances in sport and exercise. Stockholm: Human Kinetics.
   Google Scholar
• Bahrke, M. S., Yesalis, C. E., Kopstein, A. N., & Stephens, J. A. (2000). Risk factors associated with anabolic-androgenic steroid use among adolescents. Sports Medicine, 29(6), 397–405.
   PubMed Web of Science ®Google Scholar
• Bandura, A. (1977). Social learning theory. Stockholm: Prentice-Hall.
   Google Scholar
• Bandura, A. (2006). Adolescent development from an agentic perspective. In A. Bandura (ed.), Self efficacy beliefs of adolescents (pp. 1–43). Stockholm: Information Age Publishing.
   Google Scholar
• Berkowitz, A. D. (1994). Assessing collegiate substance abuse: Current trends, research needs and program applications.” In G. Gonzalez and V. Veltri (Eds.), Research and Intervention: Preventing Substance Abuse in Higher Education (pp. 3–11). Stockholm: U.S. Government Printing Office.
   Google Scholar
• Brener, N. D., McMans, T., Galuska, D. A., Lowry, R., & Weschler, H. (2003). Reliability of self reported height and weight among high school students. Journal of Adolescent Health, 32, 281–287.
   PubMed Web of Science ®Google Scholar
• Brener, N. D., Kann, L., Kinchen, S., Grunbaum, J., Whalen, L., Eaton, D., … Ross, J.G. (2004, September 24). Methodology of the youth risk behavior surveillance system. Morbidity and Mortality Weekly Report, 53(RR-12), 1–14.
   PubMedGoogle Scholar
• Buckley, W. E., Yesalis, C. E., Friedl, K. E., Anderson, W. A., Streit, A. L. & Wright, J. E. (1988). Estimated prevalence of anabolic steroid use among high school seniors. Journal of the American Medical Association, 260, 3441–3445.
   PubMed Web of Science ®Google Scholar
• Calfee, R., & Fadale, P. (2006). Popular ergogenic drugs and supplements in young athletes. Pediatrics, 117(3) , 577–589.
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention: Division of Nutrition, Physical Activity, and Obesity. (2008) About BMI for children and teens. Retrieved June 20, 2011, from http://www.cdc.gov/healthyweight/assessing/bmi/index.html
   Google Scholar
• Centers for Disease Control and Prevention. (2004, May 21). Youth Risk Behavior Survey—United States 2003. Morbidity and Mortality Weekly Report, 53; (No. SS-2). Retrieved June 20, 2011 from : http://www.cdc.gov/mmwr/PDF/ss/ss5302.pdf.
   Google Scholar
• Centers for Disease Control and Prevention. (2007). 2007 NationalYRBS data users manual. Retrieved June 20, 2011 from: http://www.cdc.gov/HealthyYouth/yrbs/index.htm.
   Google Scholar
• Compas, B. E., Oppedisano, G., Connor, J. K., Gerhardt, C. A., Hinden, B. R., Achenbach, T. M., & Hammen, C. (1997). Gender differences in depressive symptoms in adolescence: Comparison of national samples of clinically referred and non-referred youths. Journal of Consulting and Clinical Psychology, 65(4) , 617–626.
   PubMed Web of Science ®Google Scholar
• Contento, I. R. (2007). Nutrition education: Linking research, theory, and practice. Stockholm: Jones & Bartlett.
   Google Scholar
• Dennehy, C. E., Tsourounis, C., & Horn, A. (2005). Dietary supplement-related adverse events reported to the California Poison Control System. American Journal of Health-System Pharmacy. 62(14), 1476–1482.
   PubMed Web of Science ®Google Scholar
• Dhar, R., Stout, C. W., Link, M.S., Munther, K. H., Weinstock, J., & Estes, N. A. (2005). Cardiovascular toxicities of performance enhancing substances in sports. Mayo Clinic Proceedings, 80(10), 1307–1315.
   PubMed Web of Science ®Google Scholar
• Dickinson, B., Goldberg, L., Elliot, D., Spratt, D., Rogol, A. D., & Fish, L. H. (2005). Hormone abuse in adolescents and adults: A review of current knowledge. The Endocrinologist, 15(2), 115–125.
   Google Scholar
• Dodge, T. L., & Jaccard, J. J. (2006). The effect of high school sports participation on the use of performance enhancing substances in young adulthood. Journal of Adolescent Health, 39, 367–373.
   PubMed Web of Science ®Google Scholar
• Donovan, J. E., & Jessor, R. (1983). Problem drinking and the dimension of involvement with drugs: A Guttman scalogram analysis of adolescent drug use. American Journal of Public Health, 73, 543–552.
   PubMed Web of Science ®Google Scholar
• DuRant, R. H., Escobedo, L. G., & Heath, G. (1995). Anabolic steroid use, strength training, and multiple drug use among adolescents in the United States. American Academy of Pediatrics, 96(1), 23–28.
   PubMed Web of Science ®Google Scholar
• DuRant, R. H., Rickert, V. I., Ashworth, C. S., Newman, C., & Slavens, G. (1993). Use of multiple drugs among adolescents who use anabolic steroids. New England Journal of Medicine, 328, 922–926.
   PubMed Web of Science ®Google Scholar
• Eaton, D. K., Kann, L., Kinchen, S., Shanklin, S., Ross, J., Hawkins, J., … Centers for Disease Control and Prevention. (2008, June 6). Youth risk behavior surveillance-United States, 2007. Morbidity and Mortality Weekly Report, 57(No. SS-4), 1–131.
   PubMedGoogle Scholar
• Edwards, J. U., & Magel, R. (2007). Use of the Youth Risk Behavior Survey to monitor trends for nutrition and physical activity in a Midwest city school district. Journal of School Health, 77(7), 351–358.
   PubMed Web of Science ®Google Scholar
• Eisner, R. (May 18, 2001). New sports supplement warnings. Consumers Union: Andro, creatine, ephedra offer minimal benefit, pose risks. Retrieved June 16, 2011 from =1.
   Google Scholar
• Elliott, D.L., Cheong, J.W., Moe, E.L., & Goldberg, L. (2007). Cross-sectional study of female students reporting anabolic steroid use. Archives of Pediatric Adolescent Medicine (161), 572–577.
   PubMedGoogle Scholar
• Elliot, D., Goldberg, L., Moe, E., DeFrancesco, C., Durham, M., & Hix-Small, H. (2004). Preventing substance abuse and disordered eating: Initial outcomes of the ATHENA program. Archives of Pediatric Adolescent Medicine, 158, 1043–1049.
   PubMed Web of Science ®Google Scholar
• Ervin, R. B., Wright, J. D., & Reed-Gillette, D. (2004, Nov. 9). Prevalence of leading types of dietary supplements used in the third National Health and Nutrition Examination Survey, 1988–1994. Advance data for vital and health statistics, 349. Stockholm: National Center for Health Statistics.
   Google Scholar
• Fomous, C. M., Costello, R. B., & Coates, P.M. (2002). Symposium: Conference on the science and policy of performance-enhancing products. Medicine & Science in Sports & Exercise, 34(10), 1685–1690.
   PubMedGoogle Scholar
• Garzon, L. S., Ewald, R. E., Rutledge, C. M., & Meadows, T. (2006). The school nurse's role in prevention of student use of performance enhancing supplements. Journal of School Health, 76(5), 159–163.
   PubMed Web of Science ®Google Scholar
• Gilbert, B. (1969). Drugs in sport: Part 2. Something extra on the ball. Sports Illustrated, 30–42.
   Google Scholar
• Goldberg, L., Elliot, D., Clarke, G. N., MacKinnon, D. P., Moe, E., Zoref, L., … Lapin, A. (1996). Effects of a multidimensional anabolic steroid prevention intervention: The adolescents training and learning to avoid steroids (ATLAS) program. JAMA, 276(19), 1555–1562.
   PubMed Web of Science ®Google Scholar
• Greydanus, D. E., & Patel, D. R. (2005). The adolescent and substance abuse: Current concepts. Current Problems in Pediatric and Adolescent Health Care, 35(3), 78–98.
   PubMedGoogle Scholar
• Grieve, F. G. (2007). A conceptual model of factors contributing to the development of muscle dysmorphia. Eating Disorders, 15, 63–80.
   PubMedGoogle Scholar
• Guerra, L. M., Romans. P. S., Samuels, S. J., & Kass, P. H. (2000). Ethnic difference in adolescent substance initiation sequences. Archives of Pediatric Adolescent Medicine, 154, 1089–1095.
   PubMed Web of Science ®Google Scholar
• Haller, C., & Benowitz, N. (2000). Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. The New England Journal of Medicine, 343(25), 1833–1838.
   PubMed Web of Science ®Google Scholar
• Hampton, T. (2006, February 8). Researchers address use of performance enhancing drugs in nonelite athletes. Journal of the American Medical Association, 295(6), 607–608.
   Web of Science ®Google Scholar
• Hartgens, F., & Kuipers, H. (2004). Effects of androgenic-anabolic steroids in athletes. Sports Medicine, 34(8), 513–554.
   PubMed Web of Science ®Google Scholar
• Hays, R. D., Stacy, A. W., & DiMatteo, M. R. (1987). Problem behavior theory and adolescent alcohol use. Addictive Behaviors, 12, 189–193.
   PubMed Web of Science ®Google Scholar
• Held, G. (2002, April 17). Selecting and implementing model prevention programs [Electronic version]. Presented at the 2002 Northeast Centers for Application of Prevention Technologies (NE-CAPT) Video Teleconference on Implementing, Adapting, & Sustaining Model Programs. Retrieved July 1, 2004, from http://www.northeastcapt.org/resources/video_conferences/vtc2002/selecting_implementing_mp_programs.pdf.
   Google Scholar
• Huba, G. J., Wingard, J. A., & Bentler, P.M. (1981). A comparison of two latent variable causal models for adolescent drug use. Journal of Personality and Social Psychology, 40, 180–193.
   PubMed Web of Science ®Google Scholar
• Jessor, R., & Jessor, S. L. (1977). Problem behavior and psychosocial development. Stockholm: Academic Press.
   Google Scholar
• Johnson, A. O., Mink, M. D., Harun, N., Moore, C. G. Martine, A. B., & Bennett, K. J. (2008). Violence and drug use in rural teens: National prevalence estimates from the 2003 Youth Risk Behavior Survey. Journal of School Health, 78(10), 554–561.
   PubMed Web of Science ®Google Scholar
• Juhn, M. S. (2003). Popular sports supplements and ergogenic aids. Sports Medicine, 33(12), 921–939.
   PubMed Web of Science ®Google Scholar
• Kanayama, G., Pope, H. G., & Hudson, J. I. (2001). Body image drugs: A growing psychosomatic problem. Psychotherapy and Psychosomatics, 70, 61–65.
   PubMed Web of Science ®Google Scholar
• Kindlundh, A. M. S., Hagekull, B., Issacson, D. G. L., & Nyberg, F. (2001). Adolescent use of anabolic—androgenic steroids and relations to self-reports of social, personality and health aspects. The European Journal of Public Health, 3, 322–328.
   Google Scholar
• Kolbe, L. J., Kann, L., & Collins, J. L. (1993). Overview of the Youth Risk Behavior Surveillance System. Public Health Reports, 108, (Suppl. 1), 2–10.
   PubMed Web of Science ®Google Scholar
• Lehne, R. A. (2007). Pharmacology for nursing care (6th ed.). Stockholm: Elsevier.
   Google Scholar
• Luncheon, C. Bae, S., Gonzalez, A., Lurie, S., & Singh, K. P. (2008). Hispanic female adolescents’ use of illicit drugs and the risk of suicidal thoughts. American Journal of Health Behavior, 32(1), 52–59.
   PubMed Web of Science ®Google Scholar
• Martin, D. M., Baron, D. A., & Gold, M. S. (2007). A review of performance enhancing drugs in professional sports and their spread to amateur athletics, adolescents, and other at-risk populations. In M. S. Gold (Ed.), Performance enhancing medications and drugs of abuse (pp. 5–15). Stockholm: Haworth Medical Press.
   Google Scholar
• Middleman, A. B., Faulkner, A.H., Woods, E. R., Emans, S. J., & DuRant, R. H. (1995). High risk behaviors among high school students in Massachusetts who use anabolic steroids. American Academy of Pediatrics, 96(2), 268–272.
   PubMed Web of Science ®Google Scholar
• Naegle, M. A., & D'Avanzo, C. E. (2001). Addictions and substance abuse: Strategies for advanced practice nursing. Stockholm: Prentice Hall.
   Google Scholar
• National Institute on Aging. (2007, January). Pills, patches, and shots: Can hormones prevent aging? Retrieved June 16, 2011, from http://www.niapublications.org/tipsheets/pdf/Pills_Patches_and_Shots-Can_Hormones_Prevent_Aging.pdf.
   Google Scholar
• National Institute on Drug Abuse. (2000, April 14). NIDA announces multimedia public education initiative aimed at reversing rise in use of anabolic steroids by teens: National partners join effort to reach students, parents, and coaches. Retrieved June 16, 2011 from http://www.drugabuse.gov/MedAdv/00/NR4-14.html.
   Google Scholar
• National Institute on Drug Abuse [NIDA]. (2006). Research Report Series: Anabolic steroid abuse. NIDA Publication #06-3721. Retrieved June 20, 2011 from: http://www.drugabuse.gov/PDF/RRSteroids.pdf.
   Google Scholar
• Nutrition Business Journal (2007). NBJ supplement business report 2007. Retrieved May 24, 2011, from http://nbj.stores.yahoo.net/nbjsubure20.html.
   Google Scholar
• Pagonis, T. A., Angelopoulos, N. V., Kouloulis, G. N., & Hadjichristodoulou, C. S. (2006). Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse. European Psychiatry, 21, 551–562.
   PubMed Web of Science ®Google Scholar
• Palmer, M. E., Haller, C., McKinney, P. E., Klein-Schwartz, W., Tschirgi, A., Smolinske, S. C., … Landzberg, B.R. (2003, Jan. 11). Adverse events associated with dietary supplements: An observational study. The Lancet, 361, 101–106.
   PubMed Web of Science ®Google Scholar
• Parkinson, A. B., & Evans, N. A. (2006). Anabolic androgenic steroids: A survey of 500 users. Medicine & Science in Sports & Exercise, 38(4), 644–651.
   PubMed Web of Science ®Google Scholar
• Perko, M. A. (1999). Development of a theory based instrument regarding adolescent athletes and dietary supplements. American Journal of Health Studies, 15(2), 71–80.
   Google Scholar
• Perry, C. L., Baranowski, T., & Parcel, G. S. (1990). How individuals, environments, and health behavior interact: Social Learning Theory. In K. Glans, K. Lewis, B. River (Eds.), Health behavior and health education: Theory research and practice (pp. 161–186). Stockholm: Jossey-Bass.
   Google Scholar
• Petraitis, J., Flay, B. R., & Miller, T. Q. (1995). Reviewing theories of adolescent substance abuse: Organizing pieces in the puzzle. Psychological Bulletin, 117(1), 67–86.
   PubMed Web of Science ®Google Scholar
• Petroczi, A., & Naughton, D. P. (2007). Supplement use in sport: is there a potentially dangerous incongruence between rationale and practice? Journal of Occupational Medicine and Toxicology, 2(4), 1–6.
   PubMedGoogle Scholar
• Pope, H. G., Kouri, E. M., & Hudson, J. I. (2000a). Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: A randomized controlled trial. Archives of General Psychiatry, 57(2), 133–140.
   PubMed Web of Science ®Google Scholar
• Pope, H. G., Kouri, E. M., Powell, K. F., Campbell, C., & Katz, D. L. (1996). Anabolic-androgenic steroid use among 133 prisoners. Comprehensive Psychiatry, 37(5), 322–327.
   PubMed Web of Science ®Google Scholar
• Pope, H. G., Phillips, K. A., & Olivardia, R. (2000b). The Adonis complex: The secret crisis of male body obsession. Stockholm: Free Press.
   Google Scholar
• Riem, K. E., & Hursey, K. G. (1995). Using anabolic androgenic steroids to enhance physique and performance: Effects on moods and behavior. Clinical Psychology Review, 15(3), 234–256.
   Web of Science ®Google Scholar
• Shekelle, P., Morton, S., Maglione, M., Suttorp, M., Roth, E., Jungvig, L., … McKinnon, E. (2003). Ephedra and ephedrine for weight loss and athletic performance enhancement: Clinical efficacy and side effects. Evidence Report/Technology Assessment No. 76 (prepared by Southern California Evidence Based Practice Center, RAND). AHRQ Publication No. 03-E022. Rockville, MD: Agency for Research & Quality. Report retrieved June 1, 2007, from http://www.ahrq.gov/clinic/evrptpdfs.htm#ephedra.
   Google Scholar
• Sobal, J., & Marquart, L. F. (1994). Vitamin-mineral supplement use among athletes: A review of the literature. International Journal of Sports Nutrition, 4, 320–334.
   PubMed Web of Science ®Google Scholar
• Sobal, J., & Muncie, L. F. (1988). Vitamin-mineral supplement use among adolescents. Journal of Nutrition Education, 20(6), 314–318.
   Google Scholar
• Tekin, K. A., & Kravitz, L. (2004, April–May). The growing trend of ergogenic agents and supplements. ACSMs Health & Fitness Journal, 8(2), 15–18.
   Web of Science ®Google Scholar
• Thorlton, J. (2010). Adolescent performance enhancing substance use: Secondary analysis of Youth Risk Behavior Survey data (Doctoral dissertation-UMI No. 3417512).
   Google Scholar
• United States Census Bureau, Population Division. (2008, Dec. 23). National population datasets. Retrieved June 20, 2011 from: http://www.census.gov/popest/estimates.html.
   Google Scholar
• United States Census Bureau, Population Division. (2009, March 18). Census Bureau Region and Division Codes, State and County Federal Information Processing System (FIPS) Codes, and Minor Civil Divisions (MCD) and Places with Census and FIPS Codes. Census Bureau Regions and Divisions with State FIPS Codes. Retrieved June 20, 2011: http://www.census.gov/popest/estimates.html.
   Google Scholar
• United States Department of Health and Human Services. (1993). Measuring the Health Behavior of Adolescents: The Youth Risk Behavior Surveillance System and Recent Reports on High-Risk Adolescents. Public Health Reports: Journal of the U.S. Public Health Service, 108(Supplement 1), 1–96.
   Google Scholar
• United States Food and Drug Administration-Center for Food Safety and Applied Nutrition. (1995). Dietary Supplement Health and Education Act of 1994. Retrieved June 20, 2011, from http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/ucm148003.htm.
   Google Scholar
• United States Food and Drug Administration-Center for Food Safety and Applied Nutrition [USFDA-CFSAN] (2008). Dietary supplements: Overview. Retrieved June 20, 2011 from: http://www.fda.gov/Food/DietarySupplements/ConsumerInformation/ucm110417.htm.
   Google Scholar
• United States Department of Health and Human Services. (1993). Measuring the Health Behavior of Adolescents: The Youth Risk Behavior Surveillance System and Recent Reports on High-Risk Adolescents. Public Health Reports: Journal of the U.S. Public Health Service, 108(Supplement 1), 1–96.
   Google Scholar
• United States Sentencing Commission. (2006, March. 2006 Steroids report. Retrieved June 20, 2011 from: http://www.ussc.gov/Research/Working_Group_Reports/Drugs/20060323_Steroid_Report.pdf.
   Google Scholar
• Wines, J. D., Gruber, A. J., Pope, H. G., & Lukas, S. E. (1999). Nalbuphine hydrochloride dependence in anabolic steroid users. American Journal of Addiction, 8, 161–164.
   PubMed Web of Science ®Google Scholar
• World Anti-Doping Agency. (2008, Sept. 20). The World Anti-Doping Code: The 2009 prohibited list-international standard. Retrieved June 16, 2011 from: http://www.wada-ama.org/rtecontent/document/2009_Prohibited_List_ENG_Final_20_Sept_08.pdf
   Google Scholar
• World Health Organization. (2006-February). Counterfeit medicines: Fact sheet No. 275. Retrieved June 16, 2011, from: http://www.gphf.org/images/downloads/library/who_factsheet275.pdf.
   Google Scholar